BRAF inhibitors have been occasionally linked to PRES—by increasing levels of cytokines, including tumor necrosis factor-α and interferon-γ, that increase vascular permeability and potentially lead to cerebral edema [66]. Here, BRAF is linked to Posterior Leukoencephalopathy Syndrome.